TREATMENT PATTERNS AND REAL-LIFE RESPONSE IN PATIENTS WITH RELAPSED/REFRACTORY CUTANEOUS T-CELL LYMPHOMA: CLINICAL PRACTICE DATA IN SPAIN

被引：0
|
作者：
Ortiz-Romero, P. [1 ]
Pimpinelli, N. [2 ]
Illidge, T. [3 ]
Bagot, M. [4 ]
Waser, N. [5 ]
He, M. [5 ]
Zomas, A. [6 ]
Gavini, F. [6 ]
Trinchese, F. [6 ]
Little, M. [7 ]
Dalal, M. [7 ]
Assaf, C. [8 ]
机构：
[1] Hosp Univ 12 Octubre, Fac Med, Inst I 12, CIBERONC, Madrid, Spain
[2] Univ Florence, Dept Hlth Sci, Florence, Italy
[3] Univ Manchester, Christie Hosp, NIHR Biomed Ctr, Manchester, Lancs, England
[4] Hop St Louis, Polyclin Dermatol, Paris, France
[5] ICON Plc, Real World Evidence Strategy & Analyt, Vancouver, BC, Canada
[6] Takeda Pharmaceut Int AG, Zurich, Switzerland
[7] Millennium Pharmaceut Inc, Cambridge, MA USA
[8] HELIOS Klinikum Krefeld, Krefeld, Germany
来源：
HAEMATOLOGICA | 2020年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO-276
引用
收藏
页码：313 / 313
页数：1
相关论文
共 50 条
  • [31] Efficacy and Safety of AP0866 in Patients With Refractory or Relapsed Cutaneous T-Cell Lymphoma: A Phase 2 Clinical Trial
    Goldinger, Simone M.
    Bischof, Sharon Gobbi
    Fink-Puches, Regina
    Klemke, Claus-Detlev
    Dreno, Brigitte
    Bagot, Martine
    Dummer, Reinhard
    JAMA DERMATOLOGY, 2016, 152 (07) : 837 - 839
  • [32] Italian Real-Life Experience on the Use of Mogamulizumab in Patients with Cutaneous T-Cell Lymphomas
    Caruso, Laura
    Castelline, Alessia
    Dessi, Daniela
    Flenghi, Leonardo
    Giordano, Antonio
    Ibatici, Adalberto
    Massone, Cesare
    Pileri, Alessandro
    Proietti, Ilaria
    Pupo, Livio
    Quaglino, Pietro
    Rupoli, Serena
    Zinzani, Pier Luigi
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 3205 - 3221
  • [33] Bortezomib retreatment is effective in relapsed multiple myeloma patients - real-life clinical practice data
    Stork, M.
    Sevcikova, S.
    Brozova, L.
    Spicka, I
    Maisnar, V
    Minarik, J.
    Jungova, A.
    Gregora, E.
    Velichova, R.
    Hajek, R.
    Jelinek, T.
    Pour, L.
    NEOPLASMA, 2020, 67 (01) : 178 - 184
  • [34] Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma
    Chang, Esther Wei Yin
    Tan, Ya Hwee
    Chan, Jason Yongsheng
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 17 (01)
  • [35] Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma
    Laribi, Kamel
    de Materre, Alix Baugier
    Touileb, Yamina
    Boursot, Charles
    Sandrini, Jeremy
    Cavalieri, Doriane
    Pastoret, Cedric
    de Leval, Laurence
    Tournilhac, Olivier
    HEMASPHERE, 2022, 6 (02): : E675
  • [36] Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma
    Kumar, Anita
    Vardhana, Santosha
    Moskowitz, Alison J.
    Porcu, Pierluigi
    Dogan, Ahmet
    Dubovsky, Jason A.
    Matasar, Matthew J.
    Zhang, Zhigang
    Younes, Anas
    Horwitz, Steven M.
    BLOOD ADVANCES, 2018, 2 (08) : 871 - 876
  • [37] Chimeric antigen receptor T-cell treatment patterns in relapsed or refractory large B-cell lymphoma
    Seyedin, Roxanna
    Snider, Julia T.
    Rajagopalan, Krithika
    Wade, Sally W.
    Gergis, Usama
    FUTURE ONCOLOGY, 2023, 19 (22) : 1535 - 1547
  • [38] Real-life Use of Bexarotene for T-cell Cutaneous Lymphoma Management: Efficacy and Tolerance with Low Doses
    ROUANET, Jacques
    JOULIE, Ines
    LAMBERT, Celine
    D'INCAN, Michel
    ACTA DERMATO-VENEREOLOGICA, 2022, 102
  • [39] Brentuximab vedotin in the treatment of paediatric patients with relapsed or refractory Hodgkin's lymphoma: Results of a real-life study
    Massano, Davide
    Carraro, Elisa
    Mussolin, Lara
    Buffardi, Salvatore
    Barat, Veronica
    Zama, Daniele
    Muggeo, Paola
    Vendemini, Francesca
    Sau, Antonella
    Moleti, Maria Luisa
    Verzegnassi, Federico
    D'Amico, Salvatore
    Casini, Tommaso
    Garaventa, Alberto
    Schiavello, Elisabetta
    Cellini, Monica
    Vinti, Luciana
    Farruggia, Piero
    Perruccio, Katia
    Cesaro, Simone
    De Santis, Raffaela
    Marinoni, Maddalena
    D'Alba, Irene
    Mura, Rosa Maria
    Burnelli, Roberta
    Mascarin, Maurizio
    Pillon, Marta
    PEDIATRIC BLOOD & CANCER, 2022, 69 (10)
  • [40] Clinical significance of cutaneous adverse reaction to mogamulizumab in relapsed or refractory adult T-cell leukaemia-lymphoma
    Tokunaga, Masahito
    Yonekura, Kentaro
    Nakamura, Daisuke
    Haraguchi, Kouichi
    Tabuchi, Tomohisa
    Fujino, Satoshi
    Hayashida, Maiko
    Maekawa, Kenichi
    Arai, Akihiko
    Nakano, Nobuaki
    Kamada, Yuhei
    Kubota, Ayumu
    Inoue, Hirosaka
    Owatari, Satsuki
    Takeuchi, Shogo
    Takatsuka, Yoshifusa
    Otsuka, Maki
    Hanada, Shuichi
    Matsumoto, Tadashi
    Yoshimitsu, Makoto
    Ishitsuka, Kenji
    Utsunomiya, Atae
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (04) : 539 - 542
12345